Detection of ESR1 Mutations Based on Liquid Biopsy in Estrogen Receptor-Positive Metastatic Breast Cancer: Clinical Impacts and Prospects

Endocrine therapy is the main treatment option for estrogen receptor-positive (ER+) breast cancer (BC). Compared with other clinical subtypes, ER+ BC patients usually have a more favorable prognosis. However, almost all ER+ BCpatients develop endocrine resistance and disease progression eventually....

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Hao, Huang, Wenfa, Pei, Wendi, Li, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770162/
https://www.ncbi.nlm.nih.gov/pubmed/33384956
http://dx.doi.org/10.3389/fonc.2020.587671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770162/
https://www.ncbi.nlm.nih.gov/pubmed/33384956
http://dx.doi.org/10.3389/fonc.2020.587671

Ejemplares similares